| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |